Vasopressin Transdermal Patch 0.4 mg/24hr from Canada
Controlled-release transdermal patch delivering 0.4 mg vasopressin over 24 hours for chronic diabetes insipidus management. Note specifies transdermal systems; classified 3004.39.0045 as measured-dose hormone product of heading 2937.
Duty Rate — Canada → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Adhesive matrix composition and permeation testing reports required for device-drug combo clearance
• Shelf-life extension data critical for transdermal stability during ocean freight